TL;DR
Wegovy is FDA-approved for chronic weight management, but its list price (~$1,350/mo without insurance) and supply constraints push many patients toward alternatives. Several other GLP-1 medications match or exceed Wegovy's efficacy at lower cost.
Why people look for Wegovy alternatives
Before evaluating alternatives, it helps to identify which pain is driving the search — different switching reasons point to different replacements.
List price too high
Wegovy's cash price is ~$1,350/mo. Compounded semaglutide (same active ingredient) is available through telehealth for $150-300/mo.
Insurance denied coverage
Many insurers require BMI ≥30 or 27 with comorbidities AND step-therapy requirements (try and fail older drugs first). Alternatives that bypass insurance are common.
Looking for stronger results
Zepbound (tirzepatide) outperformed Wegovy in head-to-head trials — ~22% vs ~15% body weight loss.
Wegovy shortage at pharmacy
Wegovy faced extended shortages in 2023-2024 as demand outstripped supply. Compounded semaglutide became the fallback for many.
Hate weekly injections
Rybelsus (oral semaglutide) provides the same active ingredient in tablet form — daily pill instead of weekly injection.
At-a-glance comparison
6 alternatives to Wegovy, ordered by how often they’re chosen as direct replacements.
| Alternative | Best for | Type |
|---|---|---|
| Zepbound → | Patients prioritizing maximum weight loss with FDA-brand reliability. | FDA brand |
| Compounded semaglutide → | Cost-sensitive patients who can't access Wegovy via insurance. | Compounded |
| Compounded tirzepatide → | Cost-sensitive patients who want tirzepatide's efficacy without brand pricing. | Compounded |
| Ozempic → | Diabetic patients (covered by insurance for that diagnosis) who happen to also benefit from weight loss. | FDA brand |
| Saxenda → | Patients with semaglutide intolerance who need an alternative GLP-1. | FDA brand |
| Rybelsus → | Patients with needle aversion. Approved for diabetes (used off-label for weight loss). | FDA brand |
Detailed breakdown of each alternative
1. Zepbound
FDA brandTirzepatide FDA-approved for weight loss with stronger efficacy than Wegovy in head-to-head trials.
- Best for
- Patients prioritizing maximum weight loss with FDA-brand reliability.
- Honest limitation
- Higher list price, equivalent supply concerns to Wegovy.
2. Compounded semaglutide
CompoundedSame active ingredient as Wegovy at 1/4 to 1/8 the cost via telehealth providers.
- Best for
- Cost-sensitive patients who can't access Wegovy via insurance.
- Honest limitation
- Not FDA-approved as a finished product — less regulatory oversight.
3. Compounded tirzepatide
CompoundedCompounded version of Zepbound's active ingredient — stronger weight-loss potential at compounded prices.
- Best for
- Cost-sensitive patients who want tirzepatide's efficacy without brand pricing.
- Honest limitation
- Higher availability uncertainty than compounded semaglutide; same regulatory concerns.
4. Ozempic
FDA brandSame molecule as Wegovy (semaglutide), approved for type 2 diabetes. Identical clinical action.
- Best for
- Diabetic patients (covered by insurance for that diagnosis) who happen to also benefit from weight loss.
- Honest limitation
- Off-label for weight loss; insurance typically denies for that use.
5. Saxenda
FDA brandOlder FDA-approved weight-loss GLP-1 with substantial long-term data.
- Best for
- Patients with semaglutide intolerance who need an alternative GLP-1.
- Honest limitation
- Daily injection (vs weekly) and lower average weight loss (~5-8%).
6. Rybelsus
FDA brandOral semaglutide — needle-free version of Wegovy's active ingredient.
- Best for
- Patients with needle aversion. Approved for diabetes (used off-label for weight loss).
- Honest limitation
- Strict fasting protocol; less weight-loss data than injectable semaglutide.
Quick pick: which alternative for which goal
Same data, narrowed to a single recommendation per common goal. Use this when you already know what matters most.
If you want
Want the cheapest semaglutide
Our pick
Compounded semaglutide →Same molecule, ~$150-300/mo via telehealth.
If you want
Want the strongest weight loss
Our pick
Zepbound →Tirzepatide outperformed semaglutide in head-to-head trials.
If you want
Want needle-free
Our pick
Rybelsus →Oral semaglutide tablet — same active ingredient as Wegovy.
If you want
Have diabetes (insurance coverage)
Our pick
Ozempic →Same molecule, covered by insurance for diabetes diagnosis.
When to stay with Wegovy
Switching isn’t always the right answer. If your current setup meets your needs on cost, coverage, and outcomes, the friction of switching may not be worth it. Read our full Wegovy review to confirm whether the issues you’re hitting are addressable without changing medications.
FAQ — Wegovy alternatives
What is the best alternative to Wegovy?
Zepbound (tirzepatide) is the leading clinical alternative — it produced greater weight loss than Wegovy in head-to-head trials. For cost, compounded semaglutide offers the same active ingredient at a fraction of the price.
Why is Wegovy so expensive?
Wegovy's list price reflects Novo Nordisk's development costs and patent protection. With insurance, monthly cost varies $25-300; without insurance, the cash price approaches $1,350. Compounded versions of the same active ingredient are 70-85% cheaper but lack FDA oversight.
Is Zepbound or Wegovy better?
In the SURMOUNT-5 head-to-head trial (2024), Zepbound (tirzepatide) produced ~22% body-weight reduction vs ~15% for Wegovy (semaglutide) over 72 weeks. Zepbound also tends to cause less nausea at equivalent dose levels for many patients.
Editorial summary based on published clinical data, provider websites, and public pricing. GLP1Zoom earns affiliate commissions when readers visit partner websites; this does not influence ranking decisions on this page. Full affiliate disclosure. Medical disclaimer.